SE445833B - Halvester av organisk tvabasisk syra och 7-ketokolesterol eller 7-hydroxikolesterol - Google Patents

Halvester av organisk tvabasisk syra och 7-ketokolesterol eller 7-hydroxikolesterol

Info

Publication number
SE445833B
SE445833B SE8004125A SE8004125A SE445833B SE 445833 B SE445833 B SE 445833B SE 8004125 A SE8004125 A SE 8004125A SE 8004125 A SE8004125 A SE 8004125A SE 445833 B SE445833 B SE 445833B
Authority
SE
Sweden
Prior art keywords
succinate
acid
sodium
organic
hydrogen
Prior art date
Application number
SE8004125A
Other languages
English (en)
Swedish (sv)
Other versions
SE8004125L (sv
Inventor
Y Arakawa
A Takanabe
Y Uemura
S Funakoshi
D Satoh
Original Assignee
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp filed Critical Green Cross Corp
Publication of SE8004125L publication Critical patent/SE8004125L/
Publication of SE445833B publication Critical patent/SE445833B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
SE8004125A 1979-06-20 1980-06-03 Halvester av organisk tvabasisk syra och 7-ketokolesterol eller 7-hydroxikolesterol SE445833B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7676779A JPS563000A (en) 1979-06-20 1979-06-20 Water-soluble cholesterol derivative

Publications (2)

Publication Number Publication Date
SE8004125L SE8004125L (sv) 1980-12-21
SE445833B true SE445833B (sv) 1986-07-21

Family

ID=13614739

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004125A SE445833B (sv) 1979-06-20 1980-06-03 Halvester av organisk tvabasisk syra och 7-ketokolesterol eller 7-hydroxikolesterol

Country Status (7)

Country Link
US (1) US4304726A (ja)
JP (1) JPS563000A (ja)
CA (1) CA1154755A (ja)
DE (1) DE3022788C2 (ja)
FR (1) FR2459248A1 (ja)
GB (1) GB2053924B (ja)
SE (1) SE445833B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0073834B1 (en) * 1981-03-13 1986-06-25 Green Cross Corporation Water-soluble cholesterol derivatives
JPS60258198A (ja) * 1984-06-04 1985-12-20 Amano Pharmaceut Co Ltd トリテルペンアルコ−ル有機酸エステル及びその製造法
DE3803757A1 (de) * 1988-02-08 1989-08-17 Boehringer Mannheim Gmbh Cholesterin-esterase-farbsubstrat
US5496806A (en) * 1990-01-23 1996-03-05 R. Erich Klemke Glycoside compounds and production and use thereof
FI974648A (fi) 1997-09-09 1999-05-06 Raisio Benecol Oy Hydroksihappo-, maitohappo- ja hydroksialkanoaattiesterit ja niiden käyttö
US7012069B2 (en) * 2001-05-03 2006-03-14 Arch Development Corporation Liver X receptor agonists
IL146223A0 (en) 1999-04-30 2002-07-25 Arch Dev Corp Steroid derivatives
CN1498222A (zh) * 2001-02-08 2004-05-19 芝加哥大学 类固醇衍生物
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
JP4272518B2 (ja) * 2001-09-07 2009-06-03 栄次 松浦 β２−グリコプロテインＩに対するリガンド及びその用途
WO2003086303A2 (en) * 2002-04-12 2003-10-23 The University Of Chicago Farnesoid x-activated receptor agonists
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
US20100048912A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
EP2393827B1 (en) * 2009-02-05 2015-10-07 Tokai Pharmaceuticals, Inc. Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
EP2459581A4 (en) * 2009-07-29 2012-12-26 Univ Chicago LIVER X RECEPTOR AGONISTS
EP2522350B1 (de) * 2011-05-12 2013-07-31 Immunopharm AG Verwendung der Wirkstoffkombination aus einem 1-Diethylaminoethyl-3-Chinoxalin-2-on Derivat und einem Oxysterol zur Durchbrechung von Resistenzen bei der Behandlung von Krebs und zur Erhöhung der Immunleistungsfähigkeit bei Krebs, bakteriellen und viralen Erkrankungen, Autoimmunerkrankungen, erhöhter Stress- und Umweltbelastung
KR20150127720A (ko) 2013-03-14 2015-11-17 유니버시티 오브 매릴랜드, 발티모어 안드로겐 수용체 하향 조절제 및 그의 용도
BR112016002970A2 (pt) 2013-08-12 2017-09-12 Tokai Pharmaceuticals Inc biomarcadores para o tratamento de distúrbios neoplásicos que usa terapias direcionadas ao androgênio

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1224738B (de) * 1960-12-29 1966-09-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Cholestan-3, 5, 6-triol-3-estern oder -3, 6-diestern soowie von deren Salzen
GB1553540A (en) * 1977-02-23 1979-09-26 Green Cross Corp Medicaments containing cholesterol derivatives
US4202891A (en) * 1977-05-16 1980-05-13 Kandutsch Andrew A 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
US4189400A (en) * 1977-08-17 1980-02-19 Bonderman Dean P Compound useful in cholesterol assay procedures
US4225525A (en) * 1979-02-08 1980-09-30 Hoffmann-La Roche Inc. Vitamin D3 metabolite derivatives

Also Published As

Publication number Publication date
DE3022788A1 (de) 1981-01-08
FR2459248A1 (fr) 1981-01-09
CA1154755A (en) 1983-10-04
JPS563000A (en) 1981-01-13
GB2053924A (en) 1981-02-11
SE8004125L (sv) 1980-12-21
US4304726A (en) 1981-12-08
DE3022788C2 (de) 1982-08-12
FR2459248B1 (ja) 1983-10-28
GB2053924B (en) 1983-04-27

Similar Documents

Publication Publication Date Title
SE445833B (sv) Halvester av organisk tvabasisk syra och 7-ketokolesterol eller 7-hydroxikolesterol
US3266991A (en) Pharmaceutical preparations of 1-dehydro-testosterone undecyclenate
US3903089A (en) Ursolic acid derivatives
US3483191A (en) Steroids
US4069322A (en) Pro-drugs for the improved delivery of certain selected anti-inflammatory steroids
US3787396A (en) 17-hydroxy-7-(lower alkoxy)carbonyl-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid ypsilon-lactones and congeners
JPS5826899A (ja) ステロイド、その製造方法及び薬物としてのその用法
EP0065666B1 (en) Salts of cholic acids, process for their preparation and therapeutic compositions containing them as active principles
US3753979A (en) Substituted 1,2alpha-methylene-6,7alpha-halomethylene-20-spirox-4-en-3-ones or 3-ols and acyl esters thereof
US4442037A (en) Water-soluble cholesterol derivative
GB2025422A (en) 17-acetylene derivatives of androst-4-ene
KR830002844B1 (ko) 수용성 콜레스테롤 유도체의 제조방법
JPS61293993A (ja) 新規な螢光物質，その製造方法及び薬剤
US3029263A (en) 7-methyl-4, 6-androstadienes
US3483235A (en) New oestratrienes and process for their manufacture
SE448166B (sv) Derivat av 11-desoxi-17alfa-hydroxikortikosteron
US3128291A (en) New hemiacetals and hemicaetal esters of the androstane series and a method for their production
DE1568013B2 (de) 17 alpha - eckige klammer auf 3'-furyl eckige klammer zu -steroide, verfahren zu deren herstellung und diese enthaltende arzneimittel
JPH01229000A (ja) ２（３―ハイドロキシ―１，３，５（１０）―エストリエン―１７―イル）プロピオン酸の製造法
US2469967A (en) Cyclopentano perhydrophenanthrene compounds
JPH07252294A (ja) 副腎皮質ステロイド誘導体
US3422134A (en) Steroids
US3478068A (en) 4alpha,10alpha;2beta,1' - bicyclo - 5beta - methyl - 19 - nor-steroids and their preparation
KR820002232B1 (ko) 트리암시놀론 아세토니드 에스테르의 제조방법
US3673179A (en) C-21 lower alkylsulfinyl esters of certain 21-hydroxycorticosteroids

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8004125-4

Effective date: 19890725

Format of ref document f/p: F